A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
Titel:
A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
Auteur:
Sepúlveda, J. M. Belda-Iniesta, C. Gil-Gil, M. Pérez-Segura, P. Berrocal, A. Reynés, G. Gallego, O. Capellades, J. Ordoñez, J. M. Orden, B. La Balañá, C.